Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in depsipeptide research.

C E Ballard1, H Yu, B Wang

  • 1Department of Chemistry, North Carolina State University, Raleigh, NC 27695-8204, USA.

Current Medicinal Chemistry
|April 12, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Reconstruction of larynx with epiglottis and strip muscular flap after extended partial laryngectomy with T3 category].

Zhonghua er bi yan hou ke za zhi·2000
Same author

Hypersensitivity or development of antibodies to asparaginase does not impact treatment outcome of childhood acute lymphoblastic leukemia.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2000
Same author

Development of an ELISA for paraquat; improvement of antibody characteristics by reversed affinity chromatography.

The Analyst·2000
Same author

Stepwise development of thymic microenvironments in vivo is regulated by thymocyte subsets.

Development (Cambridge, England)·2000
Same author

HIV-1 strains from a cohort of American subjects reveal the presence of a V2 region extension unique to slow progressors and non-progressors.

AIDS (London, England)·2000
Same author

[Expression of FADD in primary hepatocellular carcinoma and its relationship with hepatic apoptosis].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2000
Same journal

Knockdown of circFGFR2 inhibits prostate cancer cell metastasis and proliferation by targeting miR-221-5p/ SMUG1 pathway.....

Current medicinal chemistry·2026
Same journal

LncRNA signature associated with amino acid metabolism: A novel prognostic tool for Clear Cell Renal Cell Carcinoma.

Current medicinal chemistry·2026
Same journal

HRI Kinase Modulation by BTdCPU as a Therapeutic Strategy for Bortezomib Resistance in Prostate Cancer.

Current medicinal chemistry·2026
Same journal

EGFR Dysregulation in Cancer: From Molecular Mechanisms and Key Mutations to Evolving TKI Strategies and Resistance Mitigation.

Current medicinal chemistry·2026
Same journal

DHRS2 as a Novel Thalidomide Target Regulating Mitophagy and Inflammation in Head and Neck Squamous Cell Carcinoma.

Current medicinal chemistry·2026
Same journal

Synthetic AtMP2 from Anabas testudineus: Comprehensive ADMET and In Vivo Toxicity Assessment to Enable Future Therapeutic Development.

Current medicinal chemistry·2026
See all related articles

Recent advancements in depsipeptide research highlight their therapeutic potential. These compounds show promise as anticancer, antiviral, antifungal, and anti-inflammatory agents, with some in clinical trials.

Area of Science:

  • Medicinal Chemistry
  • Natural Products Chemistry
  • Pharmacology

Background:

  • Depsipeptides are bio-oligomers formed by hydroxy and amino acids.
  • They possess diverse biological activities, including anticancer, antibacterial, antiviral, antifungal, and anti-inflammatory properties.
  • Research since 1995 has significantly advanced the understanding of depsipeptides.

Purpose of the Study:

  • To review major developments in depsipeptide research since 1995.
  • To emphasize the biological properties and therapeutic potentials of depsipeptides.
  • To discuss isolation, structural determination, and notable features of depsipeptides.

Main Methods:

  • Literature review of depsipeptide research.
  • Analysis of isolation and structural determination data.

Related Experiment Videos

  • Evaluation of biological activities and therapeutic potential.

    • Main Results:

    • Depsipeptides exhibit significant anticancer potential, with four in clinical trials.
    • Antiviral depsipeptides like callipeltins and quinoxapeptins show activity against HIV.
    • Antifungal, anti-inflammatory, and cardiovascular applications are also discussed, including compounds targeting opportunistic infections, neurokinin antagonism, and plasmin inhibition.

    Conclusions:

    • Depsipeptides represent a promising class of compounds with broad therapeutic applications.
    • Further research into depsipeptides could lead to novel treatments for cancer, viral infections, and cardiovascular diseases.
    • Specific depsipeptides are identified as potential lead compounds for drug development.